Relmada Therapeutics, Inc. (RLMD)
4.77
+0.24
(+5.30%)
USD |
NASDAQ |
Dec 31, 13:20
Relmada Therapeutics Market Cap: 349.80M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.395B |
| Invivyd, Inc. | 561.83M |
| Arcellx, Inc. | 3.738B |
| Puma Biotechnology, Inc. | 303.35M |
| Sensus Healthcare, Inc. | 62.91M |
Market Cap Related Metrics
| Price to Book Value | 36.95 |
| Price | 4.77 |
| Earnings Yield | -37.67% |